Obesity
Conference Coverage
Bariatric surgery tied to fewer HFpEF hospitalizations
News
FDA: More metformin extended-release tablets recalled
Opinion
Screaming for screens: Digital well-being in the 2020s
The COVID-19 pandemic has emphasized what was already getting louder: Screen life is becoming a ubiquitous, increasing, and normative function of...
Feature
‘Twincretin’ meets primary endpoints in five pivotal diabetes trials
From the Journals
Obesity amplifies harmful effects of alcohol on the liver
“Clinicians should consider the presence of overweight and obesity when they discuss defining safe alcohol levels for their patients,” said Dr....
From the Journals
Waist circumference a marker for NAFL in type 1 diabetes
A cross-sectional study has found that waist-to-height ratio is a sensitive marker for nonalcoholic fatty liver in type 1 diabetes.
News
FDA approves ‘game changer’ semaglutide for weight loss
Based on the STEP clinical trial results, the FDA has approved a 2.4 mg/week subcutaneous dose of the GLP-1 receptor agonist semaglutide (Wegovy,...
From the Journals
Tai chi as good as working out to shrink waistline
Researchers measured changes in waistline size, cholesterol levels, and weight for about 9 months.
Conference Coverage
Adding daily steps linked to longer life
Conference Coverage
Do anti–apo A-I antibodies link fatty liver disease and CVD?
Anti–apo A-I antibodies appear to be common in patients with NAFLD and may drive both fat deposits and proinflammatory effects in liver cells,...
From the Journals
Pericardial fat an independent risk factor for heart failure
Fat around the heart has been linked to an increased risk for heart failure, particularly in women, suggests a study using CT scans from nearly 7,...